7Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011 : The impact of eliminating socioeconomic and racial disparities on premature cancer deaths [J]. CA Cancer J Clin,2011,61 (4): 212-236.
8Innocenti F, Undevia SD, Lyer L, et al. Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan[J]. J Clin Oncol, 2004,22 (8) : 1382-1388.
9Andre T, Boni C, Navarro M, et al. Improved overall survival with oxaliplation,fluorouracil, and leucovorin as adjuvant treat- ment in stage Ⅱ or Ⅲ colon cancer in the MOSAIC trial[J]. J Clin Oncol, 2009,27 (19) : 3109-3116.
10Yokomizo H, Yoshimatsu K, Otani T, et al. Practical use of cape- citabine plus oxaliplatin(CAPEOX) with bevacizumab for patients with metastatic colorectalcancer that cannot expect conversion therapy[J]. Hepatogastroenterology, 2013,60 ( 128 ) : 1911-1915.
